Nicola Fazio, Kjell Oberg. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Combined Chemotherapy Protocols/therapeutic useClinical Trials as TopicGastrointestinal Neoplasms/drug therapyGastrointestinal Neoplasms/pathologyHumansInterferon alpha-2Interferon-alpha/administration & dosageNeuroendocrine Tumors/drug therapyNeuroendocrine Tumors/secondaryPancreatic Neoplasms/drug therapyPancreatic Neoplasms/pathologyPeptides, Cyclic/administration & dosagePrognosisRecombinant ProteinsSomatostatin/administration & dosageSomatostatin/analogs & derivatives
Substances: See more » Interferon alpha-2Interferon-alphaPeptides, CyclicRecombinant ProteinslanreotideSomatostatin
Year: 2004 PMID: 14752088 DOI: 10.1200/JCO.2004.99.180
Source DB: PubMed Journal: J Clin Oncol ISSN: 0732-183X Impact factor: 44.544